Stocks TelegraphStocks Telegraph
Stock Ideas

SLGL Company Profile and Key Details

NASDAQ : SLGL

Sol-Gel Technologies

$77.70
4.7+6.44%
At Close 4:00 PM
65.85
BESG ScoreESG Rating

Price Chart

Stock Price Today

Sol-Gel Technologies Ltd. (SLGL) stock surged +6.44%, trading at $77.70 on NASDAQ, up from the previous close of $73.00. The stock opened at $75.20, fluctuating between $74.10 and $79.30 in the recent session.

Stock Snapshot

73
Prev. Close
218.33M
Market Cap
74.1
Day Low
-35.48
P/E Ratio
-2.19
EPS (TTM)
N/A
Cash Flow per Share
75.2
Open
2.81M
Number of Shares
79.3
Day High
30%
Free Float in %
1.39
Book Value
10.45K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
May 04, 202674.7478.5373.5077.7011.55K
Apr 30, 202671.0777.2070.9074.0416.62K
Apr 29, 202671.9073.5068.2571.4026.57K
Apr 28, 202676.0076.0067.3570.9237.24K
Apr 27, 202678.0079.0371.0977.0021.07K
Apr 23, 202670.4073.1069.9072.3053.52K
Apr 22, 202675.0175.5970.5273.4829.46K
Apr 21, 202672.5076.4370.0075.8918.13K
Apr 20, 202673.8775.0069.6170.0026.39K
Apr 17, 202675.7077.2272.8373.8740.24K
Apr 16, 202680.7081.0075.0075.3242.88K
Apr 14, 202676.0077.9974.4176.5032.54K
Apr 13, 202673.2077.8872.0274.41113.18K
Apr 10, 202674.0577.8071.9074.8672.79K
Apr 09, 202672.3575.1071.1572.0272.43K
Apr 08, 202672.6775.5071.2274.50155.77K
Apr 07, 202672.3075.3569.0271.1184.96K
Apr 06, 202677.2482.9072.9074.3463.64K
Apr 02, 202682.9084.6077.4679.4680.1K
Apr 01, 202679.8985.3379.8983.5056.96K

Contact Details

Ness Ziona, 7403650

Israel

https://www.sol-gel.com972 893 13433

About Company

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Company Information

Employees34
Beta1.27
Sales or Revenue$1.55M
5Y Sales Change%6.946%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Company Overview

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) closed at $77.70 USD, gaining $4.70 (6.44%) from the previous close of $73.00. The stock is currently mid-range between its 52-week high and low $4.40 and $97.97. With a market capitalization of about $218.33 million, Sol-Gel Technologies Ltd. is classified as a micro-cap and shows market-like volatility (beta ~1.17). Key stats such as the average daily volume over the past year has been around 40.56 thousand shares, volume is running light vs its 52-week average. Headquartered in Ness Ziona, None, Sol-Gel Technologies Ltd. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Moshe Arkin, the company employs approximately 34 people and listed since February 01, 2018. Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel.

Technical Performance

SLGL has shown sold momentum, gaining 14.46% over the past week and 77.59% over the past quarter, though year-to-date performance is up 71.1%. Short-term trend indicators are bearishly aligned (SMA20 22.19%, SMA50 47.03%, SMA200 179.7%). The stock’s 14-day RSI is 70.79 (overbought), while the ATR of 7.21 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -3.1% below its high and over 2118.77% above its low. Average 10-day trading volume of 22.61 thousand shares is below the 3-month average of 39.59 thousand, indicating normal recent market interest.

Dividend & Fair Value

Sol-Gel Technologies Ltd. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$68.32. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Sol-Gel Technologies Ltd. generated EPS of -$3.23 over the past year. Five-year average earnings growth is 21.32%. Wall Street analysts project EPS growth of 12.31% annually over the next five years. The latest quarter delivered EPS of -$1.07. The next quarter is forecast at $0.39. Next year's EPS is expected at $31.68. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $110.00 to $50.00. The high target offers 41.57% upside. The low target suggests -35.65% downside. The mean target is $70.00. This offers -9.91% upside. Sol-Gel Technologies Ltd. earnings surprise history is a mixed track record. The quarter that ended March 19, 2026, missed forecasts by -374.36%. The prior quarter beat by -632.5%. Over the last six quarters, Apple has recorded several small beats. These include -92.31% in November 15, 2024.

Shareholding & Insider Activity

Sol-Gel Technologies Ltd. has 2.79 million shares outstanding. The public float is 549.97 thousand shares, elevated short interest at 1.07% of float. This equals 12.26 thousand shares. The short ratio is 0.71 days. Institutional investors hold 88.56% of the float. Insiders own 60.14%. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Frequently Asked Questions

What is the current Sol-Gel Technologies Ltd. (SLGL) stock price?
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) stock price is $77.70 in the last trading session. During the trading session, SLGL stock reached the peak price of $79.30 while $74.10 was the lowest point it dropped to. The percentage change in SLGL stock occurred in the recent session was 6.44% while the dollar amount for the price change in SLGL stock was $4.70.
SLGL's industry and sector of operation?
The NASDAQ listed SLGL is part of Biotechnology industry that operates in the broader Healthcare sector. Sol-Gel Technologies Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of SLGL?
Mr. Gilad Mamlok
Chief Financial Officer
Dr. Karine Neimann
Vice President of Projects & Planning and Chief Chemist
Mr. Moshe Arkin
Executive Chairman
Dr. Itzik Yosef
Chief Operating Officer
Dr. Alon Seri-Levy
Co-Founder, Chief Executive Officer & Director
Prof. David Avnir
Co-Founder
Ms. Tamar Fishman Jutkowitz
Vice President & Gen. Counsel
How SLGL did perform over past 52-week?
SLGL's closing price is 1,790.51% higher than its 52-week low of $4.40 where as its distance from 52-week high of $97.97 is -20.69%.
How many employees does SLGL have?
Number of SLGL employees currently stands at 34.
Link for SLGL official website?
Official Website of SLGL is: https://www.sol-gel.com
How do I contact SLGL?
SLGL could be contacted at phone 972 893 13433 and can also be accessed through its website. SLGL operates from 7 Golda Meir Street, Ness Ziona, 7403650, Israel.
How many shares of SLGL are traded daily?
SLGL stock volume for the day was 10.45K shares. The average number of SLGL shares traded daily for last 3 months was 40.56K.
What is the market cap of SLGL currently?
The market value of SLGL currently stands at $218.33M with its latest stock price at $77.70 and 2.81M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph